Literature DB >> 24587653

Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Kenichiro Yasutake1, Motoyuki Kohjima1, Kazuhiro Kotoh1, Manabu Nakashima1, Makoto Nakamuta1, Munechika Enjoji1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of health problems in Western (industrialized) countries. Moreover, the incidence of infantile NAFLD is increasing, with some of these patients progressing to nonalcoholic steatohepatitis. These trends depend on dietary habits and life-style. In particular, overeating and its associated obesity affect the development of NAFLD. Nutritional problems in patients with NAFLD include excess intake of energy, carbohydrates, and lipids, and shortages of polyunsaturated fatty acids, vitamins, and minerals. Although nutritional therapeutic approaches are required for prophylaxis and treatment of NAFLD, continuous nutrition therapy is difficult for many patients because of their dietary habits and lifestyle, and because the motivation for treatment differs among patients. Thus, it is necessary to assess the nutritional background and to identify nutritional problems in each patient with NAFLD. When assessing dietary habits, it is important to individually evaluate those that are consumed excessively or insufficiently, as well as inappropriate eating behaviors. Successful nutrition therapy requires patient education, based on assessments of individual nutrients, and continuing the treatment. In this article, we update knowledge about NAFLD, review the important aspects of nutritional assessment targeting treatment success, and present some concrete nutritional care plans which can be applied generally.

Entities:  

Keywords:  Carbohydrates; Cholesterol; Fatty acids; Nonalcoholic fatty liver disease; Nutritional therapy

Mesh:

Substances:

Year:  2014        PMID: 24587653      PMCID: PMC3930974          DOI: 10.3748/wjg.v20.i7.1756

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  144 in total

1.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease.

Authors:  Zobair M Younossi; Ancha Baranova; Katharine Ziegler; Luca Del Giacco; Karen Schlauch; Timothy L Born; Hazem Elariny; Francesco Gorreta; Amy VanMeter; Abraham Younoszai; Janus P Ong; Zachary Goodman; Vikas Chandhoke
Journal:  Hepatology       Date:  2005-09       Impact factor: 17.425

2.  Inducible nitric oxide distribution in the fatty liver of a mouse with high fat diet-induced obesity.

Authors:  Seung-Kwon Ha; Chanhee Chae
Journal:  Exp Anim       Date:  2010

3.  Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Felice Poli; Stefano Rodella; Luca Scala; Roberto Tessari; Luciano Zenari; Giancarlo Falezza
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

4.  Stages of change for reducing dietary fat intake over 18 months.

Authors:  G W Greene; S R Rossi
Journal:  J Am Diet Assoc       Date:  1998-05

5.  The prevalence of nonalcoholic fatty liver disease and its association with lifestyle/dietary habits among university faculty and staff in Chengdu.

Authors:  Lei Shi; Zhong Wu Liu; Yun Li; Cai Gong; Huan Zhang; Li Juan Song; Cheng Yu Huang; Ming Li
Journal:  Biomed Environ Sci       Date:  2012-08       Impact factor: 3.118

6.  Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease.

Authors:  Maria Cristina Elias; Edison Roberto Parise; Luciana de Carvalho; Denis Szejnfeld; João Prola Netto
Journal:  Nutrition       Date:  2009-12-22       Impact factor: 4.008

7.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Authors:  Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

8.  Sensory and social influences on ice cream consumption by males and females in a laboratory setting.

Authors:  S L Berry; W W Beatty; R C Klesges
Journal:  Appetite       Date:  1985-03       Impact factor: 3.868

9.  Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease.

Authors:  Alastair B Ross; Jean-Philippe Godin; Kaori Minehira; John P Kirwan
Journal:  Int J Endocrinol       Date:  2013-05-16       Impact factor: 3.257

10.  Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review.

Authors:  Jeroen S L de Munter; Frank B Hu; Donna Spiegelman; Mary Franz; Rob M van Dam
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

View more
  38 in total

Review 1.  Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.

Authors:  Qing Pang; Jing-Yao Zhang; Si-Dong Song; Kai Qu; Xin-Sen Xu; Su-Shun Liu; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.

Authors:  Shigeyuki Uno; Daniel W Nebert; Makoto Makishima
Journal:  Food Chem Toxicol       Date:  2018-01-31       Impact factor: 6.023

3.  Chemical inhibition of fatty acid absorption and cellular uptake limits lipotoxic cell death.

Authors:  Constance Ahowesso; Paul N Black; Nipun Saini; David Montefusco; Jessica Chekal; Chrysa Malosh; Craig W Lindsley; Shaun R Stauffer; Concetta C DiRusso
Journal:  Biochem Pharmacol       Date:  2015-09-21       Impact factor: 5.858

4.  Multiplatform metabolomic fingerprinting as a tool for understanding hypercholesterolemia in Wistar rats.

Authors:  Diana González-Peña; Danuta Dudzik; Clara Colina-Coca; Begoña de Ancos; Antonia García; Coral Barbas; Concepción Sánchez-Moreno
Journal:  Eur J Nutr       Date:  2015-05-13       Impact factor: 5.614

Review 5.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease.

Authors:  Alessandro Federico; Claudio Zulli; Ilario de Sio; Anna Del Prete; Marcello Dallio; Mario Masarone; Carmela Loguercio
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity.

Authors:  Nipun Saini; Paul N Black; David Montefusco; Concetta C DiRusso
Journal:  Biochem Biophys Res Commun       Date:  2015-08-15       Impact factor: 3.575

7.  Fatty Acid Transport Proteins: Targeting FATP2 as a Gatekeeper Involved in the Transport of Exogenous Fatty Acids.

Authors:  Paul N Black; Constance Ahowesso; David Montefusco; Nipun Saini; Concetta C DiRusso
Journal:  Medchemcomm       Date:  2016-02-19       Impact factor: 3.597

8.  Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats.

Authors:  Merve Açıkel Elmas; Nilsu Atay; Özlem Bingöl Özakpınar; Serap Arbak; Meltem Kolgazi; Göksel Şener; Feriha Ercan
Journal:  Turk J Gastroenterol       Date:  2020-09       Impact factor: 1.852

Review 9.  Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico.

Authors:  Omar Ramos-Lopez; Erika Martinez-Lopez; Sonia Roman; Nora A Fierro; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 10.  From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations.

Authors:  Charlotte J Green; Camilla Pramfalk; Karl J Morten; Leanne Hodson
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.